Neurodegenerative Disease Research, Non-GMP Synthesis of Compounds
Awarded Limited / Sole Source Justification Posted
- Solicitation number
- 75N95024Q00460
- Agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 75N95024P00615 Federal contract award
- Awardee
- Curia Global Inc.
- NAICS code
- 541380 Testing Laboratories and Services
- PSC
- Q301 Reference Laboratory Testing
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse published a Limited / Sole Source Justification Notice for a contract to provide medicinal chemistry support focused on the synthesis of up to 100 compounds in 2-10 mg quantities under non-GMP conditions. The justification for this limited/sole source procurement is provided in the attached document. An award was made on 2024-09-13 to an unknown vendor under Contract Number 75N95024P00615 for an unknown amount.
Notice text
Medicinal chemistry support focused on the synthesis of up to 100 compounds in 2-10 mg quantities under non-GMP conditions.
Awarded contract 75N95024P00615 to unknown vendor for unknown amount on 2024-09-13.
Files
| File | Type | Posted |
|---|---|---|
| 75N95024Q00460 Justification_Redacted.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| This notice | Limited / Sole Source Justification | |
| Neurodegenerative Disease Research, Non-GMP Synthesis of Compounds | Special Notice |
Similar open opportunities
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity